Richards, Merrill & Peterson, Inc. Omeros Corp Transaction History
Richards, Merrill & Peterson, Inc.
- $191 Billion
- Q4 2024
A detailed history of Richards, Merrill & Peterson, Inc. transactions in Omeros Corp stock. As of the latest transaction made, Richards, Merrill & Peterson, Inc. holds 6,900 shares of OMER stock, worth $62,927. This represents 0.04% of its overall portfolio holdings.
Number of Shares
6,900Holding current value
$62,927% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding OMER
# of Institutions
139Shares Held
25.9MCall Options Held
718KPut Options Held
598K-
Black Rock Inc. New York, NY4.1MShares$37.4 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY4.01MShares$36.6 Million1.55% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.14MShares$28.7 Million0.0% of portfolio
-
D. E. Shaw & Co., Inc. New York, NY1.84MShares$16.8 Million0.01% of portfolio
-
Stifel Financial Corp St. Louis, MO1.58MShares$14.4 Million0.02% of portfolio
About OMEROS CORP
- Ticker OMER
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,730,000
- Market Cap $572M
- Description
- Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...